Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Renal: Creatinine no greater than 2 times ULN
Cardiovascular: No clinically evident congestive heart failure, No serious cardiac arrhythmias, No prior coronary artery disease or ischemia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is studying how well BAY 59-8862 works in treating patients with advanced kidney cancer.
Who is the study for?
Adults with advanced kidney cancer who are stable and have not abused substances. They must have a certain level of blood cells, liver function within specific limits, no severe infections or hepatitis B/C, HIV negative, not pregnant or nursing, and using barrier contraception if fertile. No recent seizures or other cancers (except some skin cancers) in the last 3 years.Check my eligibility
What is being tested?
The trial is testing the effectiveness of a chemotherapy drug called BAY 59-8862 on patients with advanced kidney cancer. It's a Phase II study to see how well this drug stops tumor cells from growing or causes them to die.See study design
What are the potential side effects?
Possible side effects may include reactions similar to those seen with other chemotherapy drugs such as fatigue, nausea, hair loss, low blood cell counts leading to increased infection risk and bleeding problems. Specific side effects for BAY 59-8862 are not listed but can be expected to align with common chemo-related issues.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My kidney function, measured by creatinine, is within normal limits.
Select...
My heart is healthy with no failure, serious rhythm problems, or past heart disease.
Select...
I have not had a severe allergic reaction to taxane drugs that couldn't be managed.
Select...
My cancer has spread beyond just my brain.
Select...
My liver function tests are within acceptable ranges and I don't have chronic hepatitis B or C.
Select...
I have never had a seizure.
Select...
My kidney cancer is confirmed by lab tests.
Select...
I am 18 years old or older.
Select...
I do not have any serious infections right now.
Select...
I do not have severe numbness or pain in my hands or feet.
Select...
My cancer spots in areas treated with radiation are not counted as measurable.
Select...
I am able to get out of my bed or chair and move around.
Select...
My cancer cannot be removed by surgery and has spread.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
TheradexLead Sponsor
33 Previous Clinical Trials
1,562 Total Patients Enrolled
Marius Moscovici, MDStudy ChairPharma-Clinical
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I had brain or meningeal tumors treated over 6 months ago, with no recent growth.My kidney function, measured by creatinine, is within normal limits.My heart is healthy with no failure, serious rhythm problems, or past heart disease.I have not had a severe allergic reaction to taxane drugs that couldn't be managed.I haven't had any cancer in the last 3 years, except for specific non-aggressive types.I have not received hormonal therapy for kidney cancer.I am not currently receiving any experimental or approved cancer treatments.I am not taking bisphosphonates for bone health or cancer spread to bones, unless my doctor said it's okay.My target lesion for this study has not received prior radiotherapy, or if it has, the cancer within that area has gotten worse.I am not on blood thinners, or my blood clotting tests are normal if I am.I have not had chemotherapy that travels through my bloodstream to reach cancer cells anywhere in my body.I am not receiving any other cancer treatments.My cancer has spread beyond just my brain.My liver function tests are within acceptable ranges and I don't have chronic hepatitis B or C.I have never had a seizure.I had seizures from brain cancer but have been seizure-free for 2 months.I am not currently on any steroid treatments.I am not using herbs, acupuncture, or supplements that could affect the study.My kidney cancer is confirmed by lab tests.I am 18 years old or older.I do not have any serious infections right now.I have never received an organ transplant.I do not have severe numbness or pain in my hands or feet.My cancer spots in areas treated with radiation are not counted as measurable.I have never been treated with oxaliplatin.I am able to get out of my bed or chair and move around.My cancer cannot be removed by surgery and has spread.I had brain or meningeal tumors treated over 6 months ago, am stable, and recent scans are clear.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacant positions available in this clinical study?
"The clinicaltrials.gov website reports that this trial, initially posted on December 1st 2001 and last updated on July 23rd 2008, is no longer recruiting participants. However, there are 423 different studies presently looking for volunteers to join their trials."
Answered by AI
Are there a multitude of facilities conducting this research study within the US?
"Subjects may enroll in this medical trial at 13 different research centres, such as Scripps Clinic in La Jolla, Billings Oncology Associates in Billings and Ochsner Clinic in New Orleans."
Answered by AI
Has the FDA given its stamp of approval to this therapeutic procedure?
"As this is a Phase 2 clinical trial, wherein there is some evidence of safety but none pertaining to efficacy, the treatment received an estimated score of 2."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger